
* Chief operating officer, Dr Ursula Ney, has left the company and the Antisoma
board
* Following restructuring, board expects company's cash will be sufficient to
fund operations until the end of 2011
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News